ClearanceBrief
Recall Z-1246-2025 ยท OUT Intracranial Aneurysm Flow Diverter

Micro Therapeutics, Inc.

Medtronic Pipeline Vantage Embolization Device with Shield Technology, REF: PED3-021-350-16, PED3-021-250-14, PED3-021-350-20, PED3-021-250-20, PED3-021-300-16, PED3-021-300-20, PED3-021-275-12, PED3-021-275-16, PED3-021-325-12, PED3-021-325-14, PED3-021-325-16, PED3-021-325-20, PED3-021-250-12, PED3-021-300-14, PED3-021-250-16, PED3-021-300-12, PED3-021-275-14, PED3-021-350-14, PED3-021-350-25, P

DateMar 5, 2025 (initiated Jan 30, 2025)
StatusOpen, Classified
ReasonUse of embolization device with diameters greater-than-or-equal-to 4mm may lead to incomplete wall apposition and/or braid deformation (fish-mouthing/braid narrowing/braid collapse) noted during procedure and post-procedure, typically noted at 6-12 month imaging follow-up, potentially can lead to thrombosis and/or serious adverse events. Higher risk in females less-than-or-equal-to 45 years of age
Root causeDevice Design
ActionOn 1/30/2025, Medtronic Neurovascular mailed "Urgent Safety and Labeling Notification" recall notices to healthcare professions who were asked to do the following: Removal (retrieval) is isolated to unused inventory of the Pipeline Vantage 027 devices: 1) Remove and quarantine all unused impacted products in your inventory. 2) Return the impacted products to firm. Firm representative can assist with identifying suitable replacement product. Correction of Instructions for Use applies to Pipeline Vantage 021 devices: The key updates are: 1) Appropriate device diameter and length selection to a
Quantity7820
DistributionWorldwide distribution: US (nationwide): PR, OK, CA, MD, FL, NY, WA, MI, AL, NV, MN, NJ, IL, OH, AK, CT, TN, MO, TX, ID, AZ, WI, PA, OR, SD, VA, CO, GA, KY, IN, AR, MA, LA, NE, MT, ME, SC, DC, NC, ND, NM, IA, UT, KS, WV, NH, HI, RI. And OUS (foreign) countries of: Algeria, Argentina, Armenia, Austra
FDA recordOpen on fda.gov

510(k) clearances named in this recall

This recall record lists no 510(k) number.